SCHEMBL7652435

SCHEMBL7652435

OCCN1CCNCC1.OCCN1CCOCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.69
ALDH1A1 P00352 1/20 0.69
GLA P06280 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KEAP1 Q14145 1/20 0.42
POLB P06746 1/20 0.41
HSD17B10 Q99714 2/20 0.40
CXCR4 P61073 2/20 0.39
HPGD P15428 1/20 0.39
DUSP3 P51452 1/20 0.39
USP2 O75604 1/20 0.39
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
GSK3B P49841 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27348674 0.94 KDM4E (0.62) KDM4EALDH1A1GLASMN1; SMN2KEAP1
Piperazine SCHEMBL5309240 0.94 KDM4E (0.72) KDM4EALDH1A1GLASMN1; SMN2KEAP1
Morpholine SCHEMBL27773497 0.92 KDM4E (0.57) KDM4EALDH1A1GLASMN1; SMN2KEAP1
SCHEMBL28846659 0.90 ALDH1A1 (0.57) KDM4EALDH1A1GLASMN1; SMN2KEAP1
SCHEMBL12958951 0.90 KDM4E (0.73) KDM4EALDH1A1GLASMN1; SMN2KEAP1
SCHEMBL416345 0.89 SMN1; SMN2 (0.50) KDM4EALDH1A1GLASMN1; SMN2KEAP1
Hydrochloric Acid SCHEMBL27141329 0.87 GLA (0.48) KDM4EALDH1A1GLASMN1; SMN2KEAP1
SCHEMBL19177427 0.87 ALDH1A1 (0.54) KDM4EALDH1A1SMN1; SMN2POLBHSD17B10
SCHEMBL25262333 0.87 KDM4E (0.90) KDM4EALDH1A1GLASMN1; SMN2KEAP1
SCHEMBL13758294 0.87 KDM4E (0.90) KDM4EALDH1A1GLASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469214-B2 ETHANOLAMINE(S), OPTIONALLY IN THE PRESENCE OF AMMONIA, IS/ARE TREATED WITH A STRONG BASE BASF AKTIENGESELLSCHAFT (DE) 2002-10-22 US claimed